ROYCE & ASSOCIATES LP

Position in MYGN — Myriad Genetics Inc

CIK 906304 New York, NY

Position in MYGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$67,081

-$3,653,669 QoQ

Shares Held

11,748

-98.1% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#130

of 195 holders

Holding Since

Mar 2020

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROYCE & ASSOCIATES LP holds $37,209,349 across 4 Diagnostics & Research names. MYGN ranks #4 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CDNA	CareDx, Inc.	575,971	$16,415,173
2	RDNT	RadNet, Inc.	211,269	$13,028,959
3	WGS	GeneDx Holdings Corp.	112,136	$7,698,136
4	MYGN	Myriad Genetics Inc This page	11,748	$67,081

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$67,081	11,748	-98.1%	Shares	Sole	2026-08-14
2025-12-31	$3,720,750	605,000	-9.7%	Shares	Sole	2026-02-09
2025-09-30	$4,844,100	670,000	+21122.7%	Shares	Sole	2025-11-12
2020-06-30	$35,800	3,157	+10.0%	Shares	Sole	2020-08-07
2020-03-31	$41,069	2,870	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.